Arrhythmia
Arrhythmia(心律失常)
Arrhythmia 相关产品(82)
- GC10971Mexiletine HClCAS: 5370-01-4纯度: >99.00%
A sodium channel blocker and class Ib antiarrhythmic agent
- GC40229(±)-Warfarin-d5CAS: 75472-93-4纯度: >99.00%
An internal standard for the quantification of warfarin
- GC40235Ranolazine-d5CAS: 1092804-87-9纯度: >99.00%
An internal standard for the quantification of ranolazine
- GC40967rac-7-methoxy PropranololCAS: 76275-53-1纯度: >95.00%
An intermediate for the preparation of rac-7-hydroxy propranolol
- GC41661(±)-4-hydroxy Propranolol β-D-GlucuronideCAS: 94731-13-2纯度: >90.00%
A metabolite of propranolol
- GC42809Angiotensin II (3-8) (human, rat, mouse) (trifluoroacetate salt)纯度: >95.00%
A peptide vasoconstrictor
- GC44803rac-7-hydroxy Propranolol (hydrochloride)CAS: 76275-67-7纯度: >98.00%
An isomer and metabolite of propranolol
- GC45096Tyr-α-CGRP (human) (trifluoroacetate salt)CAS: 124756-98-5纯度: >95.00%
A tyrosinated analogue of α-CGRP
- GC45558Salbutamol-d9CAS: 1173021-73-2纯度: >99.00%
An internal standard for the quantification of salbutamol
- GC457732-chloro-N6-Cyclopentyladenosine (hydrate)CAS: 1217443-91-8纯度: >98.00%
A neuropeptide with diverse biological activities
- GC45817Quinidine-d3CAS: 1267657-68-0纯度: >99.00%
An internal standard for the quantification of quinidine
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10971 | Mexiletine HCl | 5370-01-4 | >99.00% | |
A sodium channel blocker and class Ib antiarrhythmic agent | ||||
| GC18219 | 6-hydroxy Warfarin | 17834-02-5 | >98.00% | |
A phase I metabolite of (+)-warfarin | ||||
| GC18698 | CAY10665 | 1235543-17-5 | - | |
A stable bioisostere of the antiarrhythmic 17,18-EET | ||||
| GC40229 | (±)-Warfarin-d5 | 75472-93-4 | >99.00% | |
An internal standard for the quantification of warfarin | ||||
| GC40235 | Ranolazine-d5 | 1092804-87-9 | >99.00% | |
An internal standard for the quantification of ranolazine | ||||
| GC40529 | 7-hydroxy Warfarin | 17834-03-6 | - | |
A phase I metabolite of (-)-warfarin | ||||
| GC40967 | rac-7-methoxy Propranolol | 76275-53-1 | >95.00% | |
An intermediate for the preparation of rac-7-hydroxy propranolol | ||||
| GC41661 | (±)-4-hydroxy Propranolol β-D-Glucuronide | 94731-13-2 | >90.00% | |
A metabolite of propranolol | ||||
| GC41694 | (3S)-hydroxy Quinidine | 53467-23-5 | >98.00% | |
An active quinidine metabolite | ||||
| GC42690 | Acecainide (hydrochloride) | 34118-92-8 | >98.00% | |
An active metabolite of procainamide | ||||
| GC42809 | Angiotensin II (3-8) (human, rat, mouse) (trifluoroacetate salt) | - | >95.00% | |
A peptide vasoconstrictor | ||||
| GC42966 | Bopindolol (malonate) | 82857-38-3 | >98.00% | |
A β-adrenergic receptor antagonist | ||||
| GC44112 | Mabuterol | 56341-08-3 | >98.00% | |
A β 2 -adrenergic receptor agonist | ||||
| GC44492 | O-Desmethyl Metoprolol | 62572-94-5 | >99.00% | |
A major active metabolite of metoprolol | ||||
| GC44699 | Propranolol β-D-Glucuronide (sodium salt) | - | >95.00% | |
A major metabolite of propranolol | ||||
| GC44799 | Quinidine N-oxide | 70116-00-6 | >95.00% | |
A quinidine metabolite | ||||
| GC44801 | R-(-)-Flecainide | 99495-90-6 | >98.00% | |
An antiarrhythmic agent | ||||
| GC44803 | rac-7-hydroxy Propranolol (hydrochloride) | 76275-67-7 | >98.00% | |
An isomer and metabolite of propranolol | ||||
| GC44868 | Salbutamol (hydrochloride) | 50293-90-8 | >98.00% | |
A β 2 -AR agonist | ||||
| GC45096 | Tyr-α-CGRP (human) (trifluoroacetate salt) | 124756-98-5 | >95.00% | |
A tyrosinated analogue of α-CGRP | ||||
| GC45208 | α-hydroxy Metoprolol | 56392-16-6 | >98.00% | |
An active metabolite of metoprolol | ||||
| GC45558 | Salbutamol-d9 | 1173021-73-2 | >99.00% | |
An internal standard for the quantification of salbutamol | ||||
| GC45773 | 2-chloro-N6-Cyclopentyladenosine (hydrate) | 1217443-91-8 | >98.00% | |
A neuropeptide with diverse biological activities | ||||
| GC45817 | Quinidine-d3 | 1267657-68-0 | >99.00% | |
An internal standard for the quantification of quinidine | ||||